1. MARKET INTELLIGENCE. CONSULTING www.techsciresearch.com GLOBAL PCOS TREATMENT MARKET FORECAST & OPPORTUNITIES 2015 – 2025

2. 2 Scope of Report Product of Interest (POI): PCOS Treatment Review Period 2015 – 2018 Base Year 2019 Estimated Year 2020 Forecast Period 2021 – 2025 Year Range Polycystic ovary syndrome (PCOS) is a condition that affects a woman's hormone levels. Women with PCOS produce higher-than-normal amounts of male hormones. This hormone imbalance causes them to skip menstrual periods and makes it harder for them to get pregnant. Market Segmentation DRUG Ovulation Inducing Agents Insulin-Sensitizing Agents Oral Contraceptives Antiandrogens Anti-Depressants Insulin-Sensitizing Agents Anti-Obesity Drugs Others SURGERY Ovarian Wedge Resection Cyst Aspiration Laparoscopic Ovarian Drilling DIAGNOSIS Pelvic Examination Ultrasound Blood Tests END USER Hospitals & Clinics Ambulatory Surgical Centers Fertility Clinics REGION Asia Pacific Europe North America South America Middle East & Africa

3. 3 Table of Contents S. No.Contents Page No. 1. Product Overview 2. Research Methodology 3.Impact of COVID-19 on Global PCOS Treatment Market 4.Executive Summary 5.Voice of Customer 6.Global PCOS Treatment Market Outlook 6.1.Market Size & Forecast 6.1.1.By Value 6.2.Market Share & Forecast 6.2.1. By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling) 6.2.2. By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others) 6.2.3. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests) 6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics) 6.2.5. By Company (2019) 6.2.6. By Region 6.3. Product Market Map 7.Asia-Pacific PCOS Treatment Market Outlook

4. 4 Table of Contents S. No.Contents Page No. 7.1.Market Size & Forecast 7.1.1. By Value 7.2.Market Share & Forecast 7.2.1. By Surgery 7.2.2. By Drug 7.2.3. By Diagnosis 7.2.4. By End User 7.2.5. By Country 7.3.Asia-Pacific: Country Analysis 7.3.1. China PCOS Treatment Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Surgery 7.3.1.2.2. By Drug 7.3.1.2.3. By Diagnosis 7.3.1.2.4. By End User 7.3.2. India PCOS Treatment Market Outlook 7.3.2.1.Market Size & Forecast

5. 5 Table of Contents S. No.Contents Page No. 7.3.2.1.1.By Value 7.3.2.2.Market Share & Forecast 7.3.2.2.1. By Surgery 7.3.2.2.2. By Drug 7.3.2.2.3. By Diagnosis 7.3.2.2.4. By End User 7.3.3. Australia PCOS Treatment Market Outlook 7.3.3.1.Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2.Market Share & Forecast 7.3.3.2.1. By Surgery 7.3.3.2.2. By Drug 7.3.3.2.3. By Diagnosis 7.3.3.2.4. By End User 7.3.4. Japan PCOS Treatment Market Outlook 7.3.4.1. Market Size & Forecast 7.3.4.1.1. By Value 7.3.4.2. Market Share & Forecast

6. 6 Table of Contents S. No.Contents Page No. 7.3.4.2.1. By Surgery 7.3.4.2.2. By Drug 7.3.4.2.3. By Diagnosis 7.3.4.2.4. By End User 7.3.5. South Korea PCOS Treatment Market Outlook 7.3.5.1. Market Size & Forecast 7.3.5.1.1. By Value 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Surgery 7.3.5.2.2. By Drug 7.3.5.2.3. By Diagnosis 7.3.5.2.4. By End User 8.Europe PCOS Treatment Market Outlook 8.1.Market Size & Forecast 8.1.1. By Value 8.2.Market Share & Forecast 8.2.1. By Surgery 8.2.2. By Drug

7. 7 Table of Contents S. No.Contents Page No. 8.2.3. By Diagnosis 8.2.4. By End User 8.2.5. By Country 8.3.Europe: Country Analysis 8.3.1. France PCOS Treatment Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Surgery 8.3.1.2.2. By Drug 8.3.1.2.3. By Diagnosis 8.3.1.2.4. By End User 8.3.2. Germany PCOS Treatment Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Surgery 8.3.2.2.2. By Drug

8. 8 Table of Contents S. No. Contents Page No. 8.3.2.2.3. By Diagnosis 8.3.2.2.4. By End User 8.3.3. United Kingdom PCOS Treatment Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Surgery 8.3.3.2.2. By Drug 8.3.3.2.3. By Diagnosis 8.3.3.2.4. By End User 8.3.4. Italy PCOS Treatment Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Surgery 8.3.4.2.2. By Drug 8.3.4.2.3. By Diagnosis 8.3.4.2.4. By End User

9. 9 Table of Contents S. No.Contents Page No. 8.3.5. Spain PCOS Treatment Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Surgery 8.3.5.2.2. By Drug 8.3.5.2.3. By Diagnosis 8.3.5.2.4. By End User 9.North America PCOS Treatment Market Outlook 9.1.Market Size & Forecast 9.1.1. By Value 9.2.Market Share & Forecast 9.2.1. By Surgery 9.2.2. By Drug 9.2.3. By Diagnosis 9.2.4. By End User 9.2.5. By Country 9.3.North America: Country Analysis

10. 10 Table of Contents S. No.Contents Page No. 9.3.1. United States PCOS Treatment Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Surgery 9.3.1.2.2. By Drug 9.3.1.2.3. By Diagnosis 9.3.1.2.4. By End User 9.3.2. Mexico PCOS Treatment Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Surgery 9.3.2.2.2. By Drug 9.3.2.2.3. By Diagnosis 9.3.2.2.4. By End User 9.3.3. Canada PCOS Treatment Market Outlook 9.3.3.1. Market Size & Forecast

11. 11 Table of Contents S. No.Contents Page No. 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Surgery 9.3.3.2.2. By Drug 9.3.3.2.3. By Diagnosis 9.3.3.2.4. By End User 10.South America PCOS Treatment Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Surgery 10.2.2. By Drug 10.2.3. By Diagnosis 10.2.4. By End User 10.2.5. By Country 10.3. South America: Country Analysis 10.3.1. Brazil PCOS Treatment Market Outlook 10.3.1.1. Market Size & Forecast

12. 12 Table of Contents S. No.Contents Page No. 10.3.1.1.1 By Value 10.3.1.2.Market Share & Forecast 10.3.1.2.1. By Surgery 10.3.1.2.2. By Drug 10.3.1.2.3. By Diagnosis 10.3.1.2.4. By End User 10.3.2. Argentina PCOS Treatment Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1 By Value 10.3.2.2.Market Share & Forecast 10.3.2.2.1. By Surgery 10.3.2.2.2. By Drug 10.3.2.2.3. By Diagnosis 10.3.2.2.4. By End User 10.3.3. Colombia PCOS Treatment Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1 By Value 10.3.3.2.Market Share & Forecast

13. 13 Table of Contents S. No.Contents Page No. 10.3.3.2.1. By Surgery 10.3.2.2.2. By Drug 10.3.2.2.3. By Diagnosis 10.3.2.2.4. By End User 11.Middle East and Africa PCOS Treatment Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Surgery 11.2.2. By Drug 11.2.3. By Diagnosis 11.2.4. By End User 11.2.5. By Country 11.3.Middle East & Africa : Country Analysis 11.3.1. South Africa PCOS Treatment Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast

14. 14 Table of Contents S. No.Contents Page No. 11.3.1.2.1. By Surgery 11.3.1.2.2. By Drug 11.3.1.2.3. By Diagnosis 11.3.1.2.4. By End User 11.3.2. Saudi Arabia PCOS Treatment Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Surgery 11.3.2.2.2. By Drug 11.3.2.2.3. By Diagnosis 11.3.2.2.4. By End User 11.3.3. UAE PCOS Treatment Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Surgery 11.3.3.2.2. By Drug

15. 15 Table of Contents S. No.Contents Page No. 11.3.3.2.3. By Diagnosis 11.3.3.2.4. By End User 12.Market Dynamics 12.1.Drivers 12.2.Challenges 13.Market Trends & Developments 14.Commonly Used PCOS Drugs to control different symptoms 15.Competitive Landscape 15.1.Bristol-Myers Squibb Company 15.2.Bayer AG 15.3.Pfizer, Inc. 15.4.Abbott Laboratories, Inc. 15.5.Merck & Co., Inc. 15.6.Sanofi SA 15.7.AstraZeneca Plc 15.8.Novartis AG 15.9.Teva Pharmaceutical Industries Limited 15.10.Ferring Pharmaceuticals, Inc.

16. 16 Table of Contents S. No.Contents Page No. 16.Strategic Recommendations 17.About Us & Disclaimer

17. RESEARCH METHODOLOGY

18. 18 Research Methodology Identifying Key Opinion Leaders Questionnaire Design In-depth Interviews Data Collection Developing List of Respondents Formulating Questionnaire Market Profiling Data Validation Data Analysis In-depth secondary research was conducted to determine top players in the global PCOS treatment market, overall market size and segmental market size. In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide. List of industry players and industry specialists was developed. TechSci conducted interviews with industry experts and industry players for data collection and verification. Data obtained as a result of primary and secondary research was validated through rigorous triangulation. The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global PCOS treatment market. Data Collection Data Filter & Analysis Research & Intelligence Actionable Insights Business Solution Primary Research Desk Research Company Analysis Recent Developments Market Changing Aspects/Dynamics Government Policies Conclusion Market Participants Key Strengths LinkedIn TechSci Internal Database LinkedIn TechSci Internal Database Factiva Hoovers Factiva Hoovers Paid Sources Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Body Associations, etc. Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Body Associations, etc. Secondary Research Primary Research

19. 19 Research Methodology Baseline Methodology Our dedicated team of industry experts has monitored and analyzed various aspects of the global PCOS treatment market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as increase in number of PCOS treatment and growth in healthcare sector, among others. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global PCOS treatment market. Methodology Followed for Calculation of Market Size: Market Size by Value & Volume: Market size, in terms of value & volume, for the year 2019 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as healthcare companies, channel partners, market influencers & end users, industry experts, and other industry participants. The team interviewed more than 15 – 20 PCOS treatment companies, 100 – 120 end users, and 15 – 20 industry experts and other value chain stakeholders in the global PCOS treatment market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015-2019.

20. 20 Research Methodology Respondents were asked about the current and future market growth rates, market shares by surgery, by drug, by diagnosis, by end user and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders. Methodology Followed for Calculation of Market Shares: Market shares by surgery, by drug, by Diagnosis, by end user and by region were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of PCOS treatment market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers. Methodology Followed for Forecasting: TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software. Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global PCOS treatment market, TechSci Research used various forecast techniques such as: Moving Average Time Series Analysis Regression Analysis Econometric and Judgmental Analysis

21. 21 Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million. Partial List of Companies Interviewed Key Secondary Sources  Bristol-Myers Squibb Company  Bayer AG  Pfizer, Inc.  Abbott Laboratories, Inc.  Merck & Co., Inc.  Sanofi SA  AstraZeneca Plc  Novartis AG  Teva Pharmaceutical Industries Limited  Ferring Pharmaceuticals, Inc.  World Bank  TechSci Research Proprietary Database & Knowledge Repository  Company Annual Reports  Industry Magazines  Industry Reports  News Dailies  Credible Paid Databases

22. 22 Industry Brief According to TechSci Research report, “Global PCOS Treatment Market By Treatment (Surgeries v/s Drug Treatment), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025”, the global PCOS treatment market is expected to grow at a formidable rate during the forecast period on account of the rising awareness pertaining to diseases and reproductive health among the population. Additionally, initiatives taken by various government and non-government organizations for spreading awareness and providing schemes and services for the welfare of women is further expected to positively impact the growth of market over the next few years. Furthermore, easy access to PCOS therapeutics, growing demand for PCOS medication and rising popularity of combination therapy are further expected to foster the growth of market through 2025. However, easy availability of generics and off the label drugs might hinder the growth of market during forecast period. Additionally, lack of approved therapeutics and side effects of the available drugs might hamper the growth of market over the next few years. Also, at present no targeted therapy is available for this syndrome & it is only controlled through medication and some surgical procedures. The global PCOS treatment market is segmented based on treatment, diagnosis, end user, company and region. Based on treatment the market can be bifurcated into surgeries and drug treatment. The drug treatment segment can further be categorized into oral contraceptives, antiandrogens, anti-depressants, insulin-sensitizing agents, anti-obesity drugs, others. The insulin-sensitizing agents segment is expected to dominate the market since they lower the insulin levels in blood and help in maintaining hormonal balance. The surgeries segment is further bifurcated into ovarian wedge resection and laparoscopic ovarian drilling. The ovarian wedge resection segment is expected to witness significant growth during the forecast years as this method removes some part of the ovary, which helps in regulating menstrual cycle and promotes ovulation. Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., EffRx Pharmaceuticals SA, Mylan N.V., Millendo Therapeutics, Inc. and others are some of the leading players operating in global PCOS treatment market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share. For instance, in January 2106, AstraZeneca announced that they have started start up for women health treatment and invested USD62 million in drug development for poly cystic ovarian disorder. “North America is expected to dominate the global PCOS treatment market during the forecast period, owing to the presence of well-developed healthcare infrastructure in the region. Additionally, availability of skilled medical personnel coupled with large PCOS patient pool in the region is further expected to create lucrative opportunities for the market players over the next few years. Furthermore, better reimbursement policies in the region are encouraging the population for PCOS treatment and surgeries, thereby anticipated to drive the growth of market over the next few years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

23. 23 Sample Data - Snapshot Global PCOS Treatment Market Size, By Value (USD Million), 2015–2025F CAGR By Value XX% CAGR By Value YY% North America PCOS Treatment Market Share, By Surgery, By Value, 2015–2025F United State PCOS Treatment Market Share, By Drug, By Value, 2015–2025F

24. 24 Report Ordering Report Name: GLOBAL PCOS TREATMENT MARKET FORECAST & OPPORTUNITIES 2015 – 2025 To View Sample OR Purchase Report License TypePrice Single User License$4450 Multi-User License$5450 Custom Research License$9450

25. About Us & Disclaimer TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market. Related Reports Global Spinal Cord Stimulation Devices Market By Product Type (Rechargeable v/s Non-Rechargeable) By Application (Failed Back Syndrome, Complex Regional Pain Syndrome, Degenerative Disk Disease, Unsuccessful Disk Surgery, Others) By End User (Hospitals & Clinics, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026. Global Topical Drug Delivery Market By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products) By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery) By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) By Distribution Channel (Online vs. Offline) By Region, Competition Forecast & Opportunities, 2026 The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research. TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com Disclaimer TechSci Research – Europe 54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com TechSci Research – Asia-Pacific B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com